Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
This report elaborates on the current development of the Immuno-oncology Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Roche
Amgen
Merck
Sanofi
Spectrum Pharmaceuticals
Bristol-Myers Squibb
Eli-Lilly
Janssen Biotech
Pfizer
AstraZeneca
Novartis
GlaxoSmithKline
Takeda
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
Application:
Hospitals
Ambulatory Surgical Center
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Immuno-oncology Therapy Industry Overview
-
1.1.1 Immuno-oncology Therapy Market Scope and Market Segments
-
1.1.2 Immuno-oncology Therapy Industry Characteristics
-
1.1.3 Global and China Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Immuno-oncology Therapy Production Value and Growth Rate (2017-2028)
-
1.2 Global Immuno-oncology Therapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monoclonal Antibodies
-
1.2.2 Immune Checkpoint Inhibitors
-
1.2.3 Immune System Modulators
-
1.2.4 Cancer Vaccines
-
1.2.5 Others
-
1.3 Global Immuno-oncology Therapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Ambulatory Surgical Center
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Immuno-oncology Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Immuno-oncology Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Immuno-oncology Therapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Immuno-oncology Therapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Immuno-oncology Therapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Immuno-oncology Therapy Industry Porter's Five Forces Model Analysis
-
2.2.3 Immuno-oncology Therapy Industry PEST Analysis
-
2.3 Immuno-oncology Therapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Immuno-oncology Therapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Immuno-oncology Therapy Industry
Chapter 3 Global and China Immuno-oncology Therapy Market, by Manufacturer
-
3.1 Global and China Immuno-oncology Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Immuno-oncology Therapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Immuno-oncology Therapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Immuno-oncology Therapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Immuno-oncology Therapy Market Top 3 Players
Chapter 4 Global and China Immuno-oncology Therapy Market, by Type (2017-2028)
-
4.1 Immuno-oncology Therapy Market Trend, by Type
-
4.2 Global Immuno-oncology Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Immuno-oncology Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Immuno-oncology Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Immuno-oncology Therapy Price Trend, by Type (2017-2028)
-
4.3 China Immuno-oncology Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Immuno-oncology Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Immuno-oncology Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Immuno-oncology Therapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China Immuno-oncology Therapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Immuno-oncology Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Immuno-oncology Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Immuno-oncology Therapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Immuno-oncology Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Immuno-oncology Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Immuno-oncology Therapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Immuno-oncology Therapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Immuno-oncology Therapy Market Analysis
-
7.1 North America Immuno-oncology Therapy Market, by Type
-
7.2 North America Immuno-oncology Therapy Market, by Application
-
7.3 North America Immuno-oncology Therapy Market Analysis and Forecast, by Country
-
7.3.1 United States Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Immuno-oncology Therapy Market Analysis
-
8.1 Europe Immuno-oncology Therapy Market, by Type
-
8.2 Europe Immuno-oncology Therapy Market, by Application
-
8.3 Europe Immuno-oncology Therapy Market Analysis and Forecast, by Country
-
8.3.1 Germany Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Immuno-oncology Therapy Market Analysis
-
9.1 APAC Immuno-oncology Therapy Market, by Type
-
9.2 APAC Immuno-oncology Therapy Market, by Application
-
9.3 APAC Immuno-oncology Therapy Market Analysis and Forecast, by Country
-
9.3.1 China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Immuno-oncology Therapy Market Analysis
-
10.1 Latin America, Middle East and Africa Immuno-oncology Therapy Market, by Type
-
10.2 Latin America, Middle East and Africa Immuno-oncology Therapy Market, by Application
-
10.3 Latin America, Middle East and Africa Immuno-oncology Therapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Immuno-oncology Therapy Company Profiles
-
11.1 Roche
-
11.1.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Roche Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.1.3 Roche Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Amgen
-
11.2.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Amgen Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.2.3 Amgen Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Merck
-
11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Merck Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.3.3 Merck Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Sanofi
-
11.4.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Sanofi Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.4.3 Sanofi Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Spectrum Pharmaceuticals
-
11.5.1 Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.5.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bristol-Myers Squibb
-
11.6.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.6.3 Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Eli-Lilly
-
11.7.1 Eli-Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Eli-Lilly Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.7.3 Eli-Lilly Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Janssen Biotech
-
11.8.1 Janssen Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Janssen Biotech Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.8.3 Janssen Biotech Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Pfizer
-
11.9.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Pfizer Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.9.3 Pfizer Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 AstraZeneca Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.10.3 AstraZeneca Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Novartis
-
11.11.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Novartis Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.11.3 Novartis Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 GlaxoSmithKline
-
11.12.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 GlaxoSmithKline Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.12.3 GlaxoSmithKline Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Takeda
-
11.13.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Takeda Immuno-oncology Therapy Product Profiles, Application and Specification
-
11.13.3 Takeda Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Immuno-oncology Therapy Industry Investment Prospect and Risk Assessment
-
12.1 Immuno-oncology Therapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Immuno-oncology Therapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global Immuno-oncology Therapy Production Value and Growth Rate (2017-2028)
-
Figure China Immuno-oncology Therapy Production Value and Growth Rate (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Immune Checkpoint Inhibitors (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Immune System Modulators (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Cancer Vaccines (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center (2017-2028)
-
Figure Global Immuno-oncology Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Immuno-oncology Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Immuno-oncology Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Immuno-oncology Therapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Immuno-oncology Therapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Immuno-oncology Therapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Immuno-oncology Therapy Market Share, by Manufacturer in 2021
-
Figure Global and China Immuno-oncology Therapy Market Share, by Manufacturer in 2022
-
Table Global Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Global Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Value, by Type (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Value Share, by Type (2017-2028)
-
Figure Global Immuno-oncology Therapy Price Trend, by Type (2017-2028)
-
Table China Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table China Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table China Immuno-oncology Therapy Sales Value, by Type (2017-2028)
-
Table China Immuno-oncology Therapy Sales Value Share, by Type (2017-2028)
-
Figure China Immuno-oncology Therapy Price Trend, by Type (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Global Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Value, by Application (2017-2028)
-
Table Global Immuno-oncology Therapy Sales Value Share, by Application (2017-2028)
-
Figure Global Immuno-oncology Therapy Sales Value Share, by Application (2017-2028)
-
Table China Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table China Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Table China Immuno-oncology Therapy Sales Value, by Application (2017-2028)
-
Table China Immuno-oncology Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Immuno-oncology Therapy Production, Import, Consumption and Export (2017-2022)
-
Table North America Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table North America Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure North America Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table North America Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table North America Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure North America Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure United States Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Table Europe Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table Europe Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table Europe Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table Europe Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure UK Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure France Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure France Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Table APAC Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table APAC Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table APAC Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table APAC Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure India Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure India Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Immuno-oncology Therapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Immuno-oncology Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Immuno-oncology Therapy Sales Value and Growth Rate (2017-2028)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Spectrum Pharmaceuticals Product Profiles, Application and Specification
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli-Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli-Lilly Product Profiles, Application and Specification
-
Table Eli-Lilly Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Janssen Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Janssen Biotech Product Profiles, Application and Specification
-
Table Janssen Biotech Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Immuno-oncology Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
